Phathom Pharmaceuticals, Inc. (PHAT)
12.58
+0.17
(+1.37%)
USD |
NASDAQ |
Feb 06, 16:00
12.02
-0.56
(-4.45%)
After-Hours: 20:00
Phathom Pharmaceuticals Profit Margin (Quarterly) : -60.55% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -40.15% |
| Immuneering Corp. | -- |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -88.55% |
| Return on Invested Capital | -115.5% |
| Gross Profit Margin (Quarterly) | 87.50% |
| Operating Margin (Quarterly) | -30.85% |
| Return on Net Operating Assets | -591.5% |